Inexpensive Hydroxyurea/Didanosine Combination Controls HIV Long Term

Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Inexpensive Hydroxyurea/Didanosine Combination Controls HIV Long Term

Reuters Health Information Services (10/11/99)

A recent study published in the journal AIDS Research and Human Retroviruses by American and Italian researchers has found that HIV infection can be suppressed with hydroxyurea and didanosine. The study found that in 12 HIV-infected patients, treatment with the inexpensive combination can reduce viremia and that the antiviral response to initial treatment can last for an extended amount of time. The patients were treated for an average of 122 weeks.

991012
AD991722

Copyright © 1999 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.